Abstract Since coronavirus disease-2019 (COVID-19) outbreak in January 2020, several
pieces of evidence suggested an association between the spectrum of Guillain–Barré …

Skeletal muscle‐related symptoms are common in both acute coronavirus disease (Covid)‐
19 and post‐acute sequelae of Covid‐19 (PASC). In this narrative review, we discuss …

Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

Increasing literature has linked COVID‐19 to peripheral nervous system (PNS) diseases. In
addition, as we move from the pandemic to the vaccination era, literature interest is shifting …

The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …

Background: In January 2020, the first case of Guillain Barre syndrome (GBS) due to COVID-
19 was documented in China. GBS is known to be postinfectious following several types of …

Background. Guillain-Barré syndrome (GBS) is the most common cause of flaccid paralysis,
with about 100,000 people developing the disorder every year worldwide. Recently, the …

The outbreak of the novel and highly infectious severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has resulted in hundreds of millions of infections and millions …

The concurrence of COVID-19 with Guillain-Barre syndrome (GBS) can increase the
likelihood of neuromuscular respiratory failure, autonomic dysfunction, and other life …

Abstract Background/Aims: Corona virus disease 2019 (COVID 19) is a pandemic infectious
disease of 2020, which often presents with respiratory and gastrointestinal symptoms. The …